These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20167464)

  • 21. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving from a project to programmatic response: scaling up harm reduction in Asia.
    Chatterjee A; Sharma M
    Int J Drug Policy; 2010 Mar; 21(2):134-6. PubMed ID: 20079618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiators: an examination of young injecting drug users who initiate others to injecting.
    Bryant J; Treloar C
    AIDS Behav; 2008 Nov; 12(6):885-90. PubMed ID: 18097744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Global Fund's leadership on harm reduction: 2002-2009.
    Atun R; Kazatchkine M
    Int J Drug Policy; 2010 Mar; 21(2):103-6. PubMed ID: 20171865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
    Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
    Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
    Gustafson DL; Goodyear L; Keough F
    Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The fine line between harm reduction and harm production--development of a clinical policy on femoral (groin) injecting.
    Zador D; Lintzeris N; van der Waal R; Miller P; Metrebian N; Strang J
    Eur Addict Res; 2008; 14(4):213-8. PubMed ID: 18583919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islam and harm reduction.
    Kamarulzaman A; Saifuddeen SM
    Int J Drug Policy; 2010 Mar; 21(2):115-8. PubMed ID: 20006483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public injecting among a cohort of injecting drug users in Vancouver, Canada.
    DeBeck K; Small W; Wood E; Li K; Montaner J; Kerr T
    J Epidemiol Community Health; 2009 Jan; 63(1):81-6. PubMed ID: 18628270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Threat or opportunity? Secondary exchange in a setting with widespread availability of needles.
    Lenton S; Bevan J; Lamond T
    Subst Use Misuse; 2006; 41(6-7):845-64. PubMed ID: 16809175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): a Lefebvrian analysis.
    Parkin S; Coomber R
    Health Place; 2011 May; 17(3):717-26. PubMed ID: 21440483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug use and risk among regular injecting drug users in Australia: does age make a difference?
    Degenhardt L; Kinner SA; Roxburgh A; Black E; Bruno R; Fetherston J; Fry CL
    Drug Alcohol Rev; 2008 Jul; 27(4):357-60. PubMed ID: 18584384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993.
    Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP
    AIDS; 1995 May; 9(5):493-501. PubMed ID: 7639975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Merseyside, the first harm reduction conferences, and the early history of harm reduction.
    O'Hare P
    Int J Drug Policy; 2007 Mar; 18(2):141-4. PubMed ID: 17689357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV, injecting drug use and harm reduction: a public health response.
    Ball AL
    Addiction; 2007 May; 102(5):684-90. PubMed ID: 17506148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.